Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 79 artículos Viendo del 41 al 79 de 79 artículos
Pub MED

Monitoring for drug-induced movement disorders.

Johnson BG.
Nursing. 2017 May;47(5):56-60. doi: 10.1097/01.NURSE.0000513608.71646.9d. No abstract available.
Pub MED

Stop, look, and listen: Sleep in movement disorders.

Iranzo A, Silber MH.
Mov Disord. 2017 Apr 24. doi: 10.1002/mds.27008. [Epub ahead of print] Review. No abstract available.
Pub MED

Radiofrequency Lesions through Deep Brain Stimulation Electrodes in Movement Disorders: Case Report and Review of the Literature.

Pérez-Suárez J, Torres Díaz CV, López Manzanares L, Navas García M, Pastor J, Barrio Fernández P, G de Sola R.
Stereotact Funct Neurosurg. 2017 Apr 22;95(3):137-141. doi: 10.1159/000454891. [Epub ahead of print]
Pub MED

Startle responses in functional jerky movement disorders are increased but have a normal pattern.

Dreissen YEM, Boeree T, Koelman JHTM, Tijssen MAJ.
Parkinsonism Relat Disord. 2017 Apr 6. pii: S1353-8020(17)30116-5. doi: 10.1016/j.parkreldis.2017.04.001. [Epub ahead of print]
Pub MED

Movement Disorders in Adults With Intellectual Disability and Behavioral Problems Associated With Use of Antipsychotics?

Both PH, Sonneveld DS, Beumer S, Bierma-Zeinstra SMA, Maes-Festen DAM.
J Clin Psychopharmacol. 2017 Jun;37(3):385-387. doi: 10.1097/JCP.0000000000000705. No abstract available.
Pub MED

Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study.

Miguel R, Mendonça MD, Barbosa R, Ladeira F, Lampreia T, Vale J, Bugalho P.
Ther Adv Neurol Disord. 2017 Feb;10(2):81-90. doi: 10.1177/1756285616677004. Epub 2016 Nov 21.
Pub MED

Insights into Chronic Functional Movement Disorders: The Value of Qualitative Psychiatric Interviews.

Pavletic AJ.
Psychosomatics. 2017 Jan 23. pii: S0033-3182(17)30021-X. doi: 10.1016/j.psym.2017.01.007. [Epub ahead of print] No abstract available.
Pub MED

Inhibitory dysfunction contributes to some of the motor and non-motor symptoms of movement disorders and psychiatric disorders.

Jahanshahi M, Rothwell JC.
Philos Trans R Soc Lond B Biol Sci. 2017 Apr 19;372(1718). pii: 20160198. doi: 10.1098/rstb.2016.0198. Review.
Pub MED

Movement disorders: Comparison of cognitive impairment in Parkinson disease and essential tremor.

Fyfe I.
Nat Rev Neurol. 2017 Mar 24. doi: 10.1038/nrneurol.2017.40. [Epub ahead of print] No abstract available.
Pub MED

Clinician and patient perceptions of free will in movement disorders: mind the gap.

van der Salm SM, Cath DC, Rootselaar AV, Koelman JH, de Haan RJ, Tijssen MA, Meynen G.
J Neurol Neurosurg Psychiatry. 2017 Mar 11. pii: jnnp-2016-315152. doi: 10.1136/jnnp-2016-315152. [Epub ahead of print] No abstract available.
Pub MED

Gaps and controversies in movement disorders: Introduction to the series.

Erro R, Espay AJ.
Mov Disord. 2017 Feb 24. doi: 10.1002/mds.26965. [Epub ahead of print] No abstract available.
Pub MED

Abstracts of the 1st Pan American Parkinson's Disease and Movement Disorders Congress.

[No authors listed]
Mov Disord. 2017 Feb;32 Suppl 1:S1-S90. doi: 10.1002/mds.26972. No abstract available.
Pub MED

GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype.

Arya R, Spaeth C, Gilbert DL, Leach JL, Holland KD.
Epileptic Disord. 2017 Feb 15. doi: 10.1684/epd.2017.0888. [Epub ahead of print]
Pub MED

Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations.

Högl B, Stefani A.
Mov Disord. 2017 Feb 10. doi: 10.1002/mds.26929. [Epub ahead of print] Review.
Pub MED

Sedation during surgery for movement disorders and perioperative neurological complications: an observational study comparing local anesthesia, remifentanil and dexmedetomidine.

Honorato-Cia MC, Martinez-Simón A, Guridi J, Alegre M, Nuñes-Cordoba J.
World Neurosurg. 2017 Feb 4. pii: S1878-8750(17)30117-1. doi: 10.1016/j.wneu.2017.01.094. [Epub ahead of print] No abstract available.
Pub MED

Complex regional pain syndrome in children: a systematic review of clinical features and movement disorders.

Abu-Arafeh H, Abu-Arafeh I.
Pain Manag. 2017 Mar;7(2):133-140. doi: 10.2217/pmt-2016-0036.
Pub MED

Movement disorders in 2016: from genes to phenotypes.

Calabresi P, Tambasco N.
Lancet Neurol. 2017 Jan;16(1):9-10. doi: 10.1016/S1474-4422(16)30345-3. No abstract available.
Pub MED

Posttraumatic functional movement disorders.

Ganos C, Edwards MJ, Bhatia KP.
Handb Clin Neurol. 2017;139:499-507. doi: 10.1016/B978-0-12-801772-2.00041-2.
Pub MED

Functional facial and tongue movement disorders.

Fasano A, Tinazzi M.
Handb Clin Neurol. 2017;139:353-365. doi: 10.1016/B978-0-12-801772-2.00031-X.
Pub MED

Functional eye movement disorders.

Kaski D, Bronstein AM.
Handb Clin Neurol. 2017;139:343-351. doi: 10.1016/B978-0-12-801772-2.00030-8.
Pub MED

Functional jerks, tics, and paroxysmal movement disorders.

Dreissen YE, Cath DC, Tijssen MA.
Handb Clin Neurol. 2017;139:247-258. doi: 10.1016/B978-0-12-801772-2.00021-7.
Pub MED

Voluntary or involuntary? A neurophysiologic approach to functional movement disorders.

Stenner MP, Haggard P.
Handb Clin Neurol. 2017;139:121-129. doi: 10.1016/B978-0-12-801772-2.00011-4.
Pub MED

High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.

Mentzel TQ, Lieverse R, Bloemen O, Viechtbauer W, van Harten PN; Genetic Risk and Outcome of Psychosis (GROUP) Investigators..
J Clin Psychopharmacol. 2017 Jan 30. doi: 10.1097/JCP.0000000000000666. [Epub ahead of print]
Pub MED

Movement Disorders in 18p Deletion Syndrome: A Case Report and Review of Literature.

Kumar N, Rizek P, Jog M.
Can J Neurol Sci. 2017 Jan 31:1-3. doi: 10.1017/cjn.2016.444. [Epub ahead of print] No abstract available.
Pub MED

Current applications and limitations of surgical treatments for movement disorders.

Krack P, Martinez-Fernandez R, Del Alamo M, Obeso JA.
Mov Disord. 2017 Jan;32(1):36-52. doi: 10.1002/mds.26890. Review.
Pub MED

Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: A meta-analysis.

Alomar S, King NK, Tam J, Bari AA, Hamani C, Lozano AM.
Mov Disord. 2017 Jan;32(1):53-63. doi: 10.1002/mds.26924. Review.
Pub MED

Psychodynamic Psychotherapy for Functional (Psychogenic) Movement Disorders.

Sharma VD, Jones R, Factor SA.
J Mov Disord. 2017 Jan;10(1):40-44. doi: 10.14802/jmd.16038.
Pub MED

Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

Honorat JA, McKeon A.
Curr Neurol Neurosci Rep. 2017 Jan;17(1):4. doi: 10.1007/s11910-017-0709-2. Review.
Pub MED

Brain Calcification and Movement Disorders.

Kostić VS, Petrović IN.
Curr Neurol Neurosci Rep. 2017 Jan;17(1):2. doi: 10.1007/s11910-017-0710-9. Review.
Pub MED

Zolpidem in movement disorders after cardiac arrest.

Arruda WO, Silva MS, Bertholdo DB, Munhoz RP, Teive HA.
Parkinsonism Relat Disord. 2017 Jan 11. pii: S1353-8020(17)30007-X. doi: 10.1016/j.parkreldis.2017.01.007. [Epub ahead of print] No abstract available.
Pub MED

Movement disorders in 2016: Progress in Parkinson disease and other movement disorders.

Jankovic J.
Nat Rev Neurol. 2017 Feb;13(2):76-78. doi: 10.1038/nrneurol.2016.204. No abstract available.
Pub MED

Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.

Selfani K, Soland VL, Chouinard S, Huot P.
Neurologist. 2017 Jan;22(1):24-28. doi: 10.1097/NRL.0000000000000096.
Pub MED

Intraoperative electrocorticography for physiological research in movement disorders: principles and experience in 200 cases.

Panov F, Levin E, de Hemptinne C, Swann NC, Qasim S, Miocinovic S, Ostrem JL, Starr PA.
J Neurosurg. 2017 Jan;126(1):122-131. doi: 10.3171/2015.11.JNS151341.
Pub MED

Molecular Imaging of Extrapyramidal Movement Disorders.

Frey KA.
Semin Nucl Med. 2017 Jan;47(1):18-30. doi: 10.1053/j.semnuclmed.2016.09.007. Review.
Pub MED

Clinical decision-making in functional and hyperkinetic movement disorders.

van der Salm SM, van Rootselaar AF, Cath DC, de Haan RJ, Koelman JH, Tijssen MA.
Neurology. 2017 Jan 10;88(2):118-123. doi: 10.1212/WNL.0000000000003479.
Pub MED

Hyperkinetic psychogenic movement disorders remain a diagnosis at first sight.

Hedera P, Gambardella A.
Neurology. 2017 Jan 10;88(2):114-115. doi: 10.1212/WNL.0000000000003494. No abstract available.
Pub MED

Psychogenic Movement Disorders and Dopamine Transporter Scans: Still a Clinical Diagnosis?

Moguel-Cobos G, Maroney Z, Erickson JM, Tröster AI, Quinn DK.
Psychosomatics. 2017 Jan - Feb;58(1):83-89. doi: 10.1016/j.psym.2016.08.009. No abstract available.
Pub MED

Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.

Mallik AK, Drzezga A, Minoshima S.
PET Clin. 2017 Jan;12(1):119-136. doi: 10.1016/j.cpet.2016.08.003. Review.
Pub MED

Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.

Dressler D, Bhidayasiri R, Bohlega S, Chahidi A, Chung TM, Ebke M, Jacinto LJ, Kaji R, Koçer S, Kanovsky P, Micheli F, Orlova O, Paus S, Pirtosek Z, Relja M, Rosales RL, Sagástegui-Rodríguez JA, Schoenle PW, Shahidi GA, Timerbaeva S, Walter U, Saberi FA.
J Neurol. 2017 Jan;264(1):112-120. doi: 10.1007/s00415-016-8304-z.
Viendo del 41 al 79 de 79 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.